CoChat

Effect of spironolactone on patients with resistant hypertension and obstructive sleep apnea

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: To examine whether spironolactone could reduce the severity of obstructive sleep apnea (OSA) and lower blood pressure in patients with resistant hypertension. METHODS: This was a blank-controlled, single-center study. Patients with resistant hypertension and moderate-to-severe OSA (apnea-hypopnea index >15 events/h) were enrolled and randomly assigned to the therapy or control group. Patients in the therapy group were administered spironolactone 20 mg once daily (up to 40 mg once daily for 4 weeks, if required) in addition to original antihypertensive medication. Follow-up was 12 weeks. RESULTS: Thirty patients were enrolled (n = 15 per group). After 12 weeks of follow-up, apnea-hypopnea index (21.8 ± 15.7 vs. 1.8 ± 12.8, p < 0.05), hypopnea index (9.8 ± 11.1 vs. -2.7 ± 16.8, p < 0.05), oxygen desaturation index (20.8 ± 15.0 vs. 0.3 ± 16.1, p < 0.05), clinical blood pressure, ambulatory blood pressure, and plasma aldosterone level (9.8 ± 6.3 vs. 2.9 ± 6.7, p < 0.05) were reduced significantly in the therapy group compared with the control group. No side effects were reported. CONCLUSIONS: Spironolactone reduced the severity of OSA and reduced blood pressure in resistant hypertension patients with moderate-to-severe OSA. These findings may assist in the treatment of OSA in patients with resistant hypertension.

Overview

Integrity signals

Registry

Crossref · 10.3109/10641963.2015.1131290

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 31 references

Research works printed but not linked: 5

  1. Berry RB, 2012, Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events, 8, 597
  2. 2013, ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens 2013, 31, 1925
  3. Epstein LJ, 2009, J Clin Sleep Med: JCSM: Off Publ Am Acad Sleep Med, 5, 263
  4. Giles TL, 2006, The Cochrane Database of Syst Rev, Cd001106
  5. Gonzaga CC, 2010, J Clin Sleep Med: JCSM: Off Publ Am Acad Sleep Med, 6, 363

Cited by

See all 105

Metadata

Authors
Yang, L., Zhang, H., Cai, M., Zou, Y., Jiang, X., Song, L., Liang, E., Bian, J., Wu, H., & Hui, R.
Affiliations
  • Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
  • Chronic Disease Department, Centers for Disease Control, Hebukesaier County, Xinjiang Uygur Autonomous Region, China
Corresponding author
Zhang, Huimin
Venue
Clinical and Experimental Hypertension
Published
2016-07-01
Volume
38
Issue
5
Pages
464-468
ISSN
  • 0148-3927 (ISSN-L)
  • 1064-1963
  • 1525-6006
OpenAlex
W2463367688
Cited by
99
References
31
Citations by year
2026: 6 · 2025: 12 · 2024: 12 · 2023: 8 · 2022: 11 · 2021: 10 · 2020: 10 · 2019: 13 · 2018: 8 · 2017: 6 · 2016: 2
FWCI
7.77
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical and Experimental Hypertension (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords
spironolactone, resistant hypertension, obstructive sleep apnea, apnea-hypopnea index, blood pressure reduction, plasma aldosterone, oxygen desaturation, hypopnea, ambulatory blood pressure
MeSH terms
Adult, Aged, Mineralocorticoid Receptor Antagonists, Antihypertensive Agents, Blood Pressure, Drug Administration Schedule, Drug Resistance, Drug Therapy, Combination, Female, Humans, Hypertension, Male, Middle Aged, Spironolactone, Polysomnography, Blood Pressure Monitoring, Ambulatory, Sleep Apnea, Obstructive

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of spironolactone on patients with resistant hypertension and obstructive sleep apnea. https://app.cochat.ai/papers/10.3109/10641963.2015.1131290
The paper
Yang, L., Zhang, H., Cai, M., Zou, Y., Jiang, X., Song, L., Liang, E., Bian, J., Wu, H., & Hui, R. (2016). Effect of spironolactone on patients with resistant hypertension and obstructive sleep apnea. Clinical and Experimental Hypertension. https://doi.org/10.3109/10641963.2015.1131290

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.